J 2017

Performance indicators in a newly established organized cervical screening programme: registry-based analysis in the Czech Republic

MÁJEK, Ondřej, Jaroslava DUŠKOVÁ, Vladimír DVOŘÁK, Alena BEKOVÁ, Daniel KLIMEŠ et. al.

Základní údaje

Originální název

Performance indicators in a newly established organized cervical screening programme: registry-based analysis in the Czech Republic

Autoři

MÁJEK, Ondřej (203 Česká republika, garant, domácí), Jaroslava DUŠKOVÁ (203 Česká republika), Vladimír DVOŘÁK (203 Česká republika), Alena BEKOVÁ (203 Česká republika), Daniel KLIMEŠ (203 Česká republika, domácí), Milan BLAHA (203 Česká republika, domácí), Ahti ANTTILA (246 Finsko) a Ladislav DUŠEK (203 Česká republika, domácí)

Vydání

European Journal of Cancer Prevention, Philadelphia, Lippincott Williams Wilkins, 2017, 0959-8278

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30204 Oncology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 2.886

Kód RIV

RIV/00216224:14110/17:00096428

Organizační jednotka

Lékařská fakulta

UT WoS

000398812900008

Klíčová slova anglicky

mass screening; Pap smear; performance indicators; cervical cancer

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 20. 3. 2018 18:23, Soňa Böhmová

Anotace

V originále

In 2008, the organized Czech National Cervical Cancer Screening Programme (CNCCSP) was initiated by transformation of the existing opportunistic efforts. The aim of our study was to examine recent cervical cancer burden trends and to assess the quality of the Czech National Cervical Cancer Screening Programme using a set of standard performance indicators. Our study utilized data from the national Cervical Cancer Screening Registry and the Czech National Cancer Registry. We computed internationally accepted indicators and assessed time trends and variability among screening centres. Between 1995 and 2011, the incidence of age-standardized cervical cancer decreased by 21% (1023 cases in 2011), and the mortality decreased by 35% (399 deaths in 2011). The annual coverage of the target population by cervical screening increased to 56% in 2013 (as compared with 35% in 2001). If we consider a 2-year interval (2012–2013), the estimated coverage was 77%. Over two million women underwent screening in 2013; 96% of them had a negative result. About 0.2% of smears showed cytological signs of a high-grade intraepithelial lesion or a malignancy, and the estimated positive predictive value for advanced intraepithelial neoplasia (cervical intraepithelial neoplasia grade 2+) was 79.6%. However, performance indicators show considerable heterogeneity between screening centres. The reported values of performance indicators are in line with the results of programmes that have previously been shown to be successful in terms of decreasing the cervical cancer burden, and are promising with respect to an even more pronounced decrease in cervical cancer mortality in the near future, provided that continuous quality improvement can be maintained. Linkage studies between screening, cancer and cause-of-death registers can provide further information on screening effectiveness and validity issues.